مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

306
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

219
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

3

Information Journal Paper

Title

Repeated Intraportal Injection of Mesenchymal Stem Cells in Combination with Pioglitazone in Patients with Compensated Cirrhosis: A Clinical Report of Two Cases

Pages

  131-136

Abstract

 BACKGROUND: Transplantation of mesenchymal stem cells (MSCs) in combination with pioglitazone, an agonist of peroxisome proliferator-activated receptor-γ (PPAR-γ ), can reduce liver fibrosis in models of liver injury. In this study, we conducted a pilot study of intraportal infusion of autologous MSCs in combination with pioglitazone to assess safety, feasibility, and effectiveness in patients with compensated cirrhosis. METHODS: Two patients with compensated cirrhosis were enrolled in this study. Intraportal autologous bone marrow-derived MSCs were transplanted twice (6 months interval) to the patients. Meanwhile, 30 mg/day pioglitazone was prescribed for 12 months. Patients were assessed at baseline and months 1, 3, 6, and 12 post-infusion. RESULTS: Procedural complications or any major adverse effects did not occur in this pilot study. The patients' clinical conditions remained stable with no evidence of deterioration during the course of the study. A transient improvement in the Model for End-Stage Liver Disease (MELD) score was observed at month 3 post-infusion in one patient, which eventually returned to baseline at month 12. CONCLUSION: The combination of pioglitazone with MSCs is safe and feasible. The data justify further study of the combination therapy in cirrhotic patients.

Cites

References

  • No record.

    • Cite

    APA: Copy

    VOSOUGH, MASSOUD, MOOSSAVI, SHIRIN, MARDPOUR, SOURA, AKHLAGHPOOR, SHAHRAM, AZIMIAN, VAJIHEH, Jarughi, Neda, HOSSEINI, SEYEDEH ESMAT, ASHRAFI, MANDANA, NIKFAM, SEPIDEH, AGHDAMI, NASSER, MALEKZADEH, REZA, MOHAMADNEJAD, MEHDI, & BAHARVAND, HOSSEIN. (2016). Repeated Intraportal Injection of Mesenchymal Stem Cells in Combination with Pioglitazone in Patients with Compensated Cirrhosis: A Clinical Report of Two Cases. ARCHIVES OF IRANIAN MEDICINE, 19(2), 131-136. SID. https://sid.ir/paper/281444/en

    Vancouver: Copy

    VOSOUGH MASSOUD, MOOSSAVI SHIRIN, MARDPOUR SOURA, AKHLAGHPOOR SHAHRAM, AZIMIAN VAJIHEH, Jarughi Neda, HOSSEINI SEYEDEH ESMAT, ASHRAFI MANDANA, NIKFAM SEPIDEH, AGHDAMI NASSER, MALEKZADEH REZA, MOHAMADNEJAD MEHDI, BAHARVAND HOSSEIN. Repeated Intraportal Injection of Mesenchymal Stem Cells in Combination with Pioglitazone in Patients with Compensated Cirrhosis: A Clinical Report of Two Cases. ARCHIVES OF IRANIAN MEDICINE[Internet]. 2016;19(2):131-136. Available from: https://sid.ir/paper/281444/en

    IEEE: Copy

    MASSOUD VOSOUGH, SHIRIN MOOSSAVI, SOURA MARDPOUR, SHAHRAM AKHLAGHPOOR, VAJIHEH AZIMIAN, Neda Jarughi, SEYEDEH ESMAT HOSSEINI, MANDANA ASHRAFI, SEPIDEH NIKFAM, NASSER AGHDAMI, REZA MALEKZADEH, MEHDI MOHAMADNEJAD, and HOSSEIN BAHARVAND, “Repeated Intraportal Injection of Mesenchymal Stem Cells in Combination with Pioglitazone in Patients with Compensated Cirrhosis: A Clinical Report of Two Cases,” ARCHIVES OF IRANIAN MEDICINE, vol. 19, no. 2, pp. 131–136, 2016, [Online]. Available: https://sid.ir/paper/281444/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button